PTC Therapeutics, Inc. Financial Ratios — BH3 Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-43.1	-65	-82.24	-57.24	-50.51	-53.24	-81.42	-216.75	- -	- -	- -	- -
Return on Assets (%)	- -	-91.7	-62.52	-38.65	-48.8	-44.79	-23.9	-16.95	-18.34	-22.87	-25.27	-30.68	-34.8	-20.18	29.66
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	42.94
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	43.94
Gross Margin (%)	- -	100	100	100	100	100	97.65	95.21	96.05	95.03	94	93.61	93.02	92.89	97.28
EBITDA Margin (%)	33.8	-83.76	-123.94	-384.94	-446.76	-155.7	-23.98	-33.84	-68.08	-101.97	-57.61	-45.59	-21.64	-28.13	52.34
Operating Margin (%)	30.9	-93.15	-130.85	-393.79	-454.58	-159.67	-33.07	-36.39	-62.8	-104.49	-69.62	-62.95	-37.26	-18.19	49.49
Incremental Operating Margin (%)	- -	81.77	- -	571.53	- -	76.34	60.67	- -	- -	- -	14.53	- -	37.87	- -	108.59
Pretax Margin (%)	28.9	-91.16	-148.65	-389.96	-462.28	-171.14	-39.95	-48.39	-78.16	-105.82	-96.24	-84.07	-74.23	-45.01	40.25
Profit Margin (%)	31.23	-91.16	-148.65	-371.37	-463.6	-171.83	-40.64	-48.38	-81.95	-115.07	-97.27	-80	-66.81	-45.03	39.44
Net Income to Common Margin (%)	0.03	-551.95	-191.47	-371.37	-463.6	-171.83	-40.64	-48.38	-81.95	-115.07	-97.27	-80	-66.81	-45.03	39.44
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.01
Dvd Payout Ratio (%)	-118,448.9	83.48	22.37	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-43.1	-65	-82.24	-57.24	-50.51	-53.24	-81.42	-216.75	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	12	5	- -	- -	92	98	145	153	328	420	1,269	1,462	2,229	2,471	2,707
ST Debt	7	4	- -	- -	- -	- -	- -	12	25	9	219	85	210	271	585
LT Debt	5	- -	- -	- -	92	98	145	141	303	412	1,050	1,377	2,019	2,200	2,122
Total Debt/EBITDA	0.35	-0.2	- -	- -	-0.56	-0.76	-3.11	-1.71	-1.57	-1.08	-4.09	-4.59	-10.99	-10.89	2.99
Net Debt/EBITDA	-0.5	-0.09	0.36	0.51	-0.21	-0.31	-0.71	0.18	-0.12	-0.26	-3.14	-3.3	-7.41	-7	1.78
Total Debt/EBIT	0.38	-0.18	- -	- -	-0.55	-0.74	-2.25	-1.32	-1.36	-0.97	-3.39	-3.27	-5.07	-8.17	3.12
Net Debt/EBIT	-0.55	-0.08	0.34	0.5	-0.2	-0.3	-0.52	0.14	-0.11	-0.23	-2.61	-2.35	-3.42	-5.25	1.86
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	-7.14	-16.73	-6.89	-3.61	-3.51	-1.57	-1.36	5.95
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	-8.37	-20.37	-7.88	-4.6	-5.18	-2.5	-1.8	3.98
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	-7.67	-15.43	-7.06	-4.36	-4.84	-2.7	-0.88	5.63
Interest Expense	- -	- -	- -	- -	- -	- -	- -	13	12	56	86	91	129	167	152
Common Equity/Total Assets	-540.46	-762.22	89.89	89.57	61.87	44.4	39.94	31.34	36.6	21.83	0.07	-20.35	-43.18	-64.4	-7.08
Long-Term Debt/Equity (%)	- -	- -	- -	- -	40.64	82.13	92.67	40.3	50.96	85.42	73,036.16	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-2	-3.07	- -	- -	28.9	45.09	48.1	28.06	32.84	45.62	82.65	123.56	143.12	160.22	84.82
Long-Term Debt/Total Assets (%)	10.3	3.36	- -	- -	25.14	36.46	37.02	12.63	18.65	18.64	54.19	80.73	106.49	129.02	73.2
Total Debt/Equity (%)	-4.9	-25.44	0.04	- -	40.64	82.13	92.67	43.63	55.19	87.23	88,272.88	-421.08	-272.32	-225.04	-1,318.51
Total Debt/Capital (%)	-5.15	-34.12	0.04	- -	28.9	45.09	48.1	30.38	35.56	46.59	99.89	131.14	158.03	179.98	108.21
Total Debt/Total Assets (%)	26.48	37.35	0.03	- -	25.14	36.46	37.02	13.67	20.2	19.04	65.5	85.69	117.59	144.93	93.39
Net Debt to Equity	7.02	-11.24	-11.25	-16.67	14.97	33.36	21.21	-4.7	4.35	20.82	67,851.25	-302.45	-183.78	-144.57	-784.34
Net Debt/Capital (%)	6.56	-12.66	-12.68	-20	13.02	25.02	17.5	-4.93	4.07	14.47	90.25	125.78	184.22	267.57	106.15
EBITDA	33	-24	-43	-97	-164	-129	-47	-90	-209	-388	-310	-319	-203	-227	906
EBITDA-CapEx	33	-24	-44	-102	-167	-131	-127	-105	-254	-444	-396	-471	-324	-301	606
Operating Income (Loss)	31	-27	-45	-99	-167	-132	-64	-96	-193	-398	-375	-440	-349	-147	857

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.66	0.1	10.85	9.71	7.47	4.67	2.33	1.36	2.91	3.98	1.52	1.01	1.45	1.96	2.01
Current Ratio	0.77	0.16	11.04	9.96	7.84	5.27	3.04	1.92	3.3	4.44	1.87	1.71	2.02	2.35	2.35
Quick Ratio	0.69	0.13	10.92	9.84	7.71	5.17	2.82	1.77	3.15	4.23	1.74	1.39	1.72	2.23	2.2
CFO/Avg Current Liab	- -	-1.34	-2.27	-2.51	-3.19	-2.18	-0.15	-0.22	-0.49	-0.76	-0.64	-0.78	-0.31	-0.18	0.92
Common Equity/Total Assets	-540.46	-762.22	89.89	89.57	61.87	44.4	39.94	31.34	36.6	21.83	0.07	-20.35	-43.18	-64.4	-7.08
Long-Term Debt/Equity (%)	- -	- -	- -	- -	40.64	82.13	92.67	40.3	50.96	85.42	73,036.16	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-2	-3.07	- -	- -	28.9	45.09	48.1	28.06	32.84	45.62	82.65	123.56	143.12	160.22	84.82
Long-Term Debt/Total Assets (%)	10.3	3.36	- -	- -	25.14	36.46	37.02	12.63	18.65	18.64	54.19	80.73	106.49	129.02	73.2
Total Debt/Equity (%)	-4.9	-25.44	0.04	- -	40.64	82.13	92.67	43.63	55.19	87.23	88,272.88	-421.08	-272.32	-225.04	-1,318.51
Total Debt/Capital (%)	-5.15	-34.12	0.04	- -	28.9	45.09	48.1	30.38	35.56	46.59	99.89	131.14	158.03	179.98	108.21
Total Debt/Total Assets (%)	26.48	37.35	0.03	- -	25.14	36.46	37.02	13.67	20.2	19.04	65.5	85.69	117.59	144.93	93.39
CFO/Total Liabilities	-7.34	-148.54	-305.46	-164.81	-89.27	-69.15	-4.28	-3.6	-9.58	-11.24	-12.98	-17.37	-5.84	-3.84	22.91
CFO/CapEx	-125.77	-253.59	-55.46	-12.28	-45.71	-58.31	-0.13	-1.78	-2.17	-3.47	-2.95	-2.34	-1.31	-1.45	2.37
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	9.34	4.73	4.59	5.95	4.89	4.97	6.07	5.97	5.25	5.93	5.05	10.18
Days Sales Outstanding	- -	- -	- -	39.06	77.13	79.49	61.33	74.66	73.39	60.14	61.12	69.49	61.58	72.25	35.87
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	0.94	0.69	1	1.87	2.37	2.5	2.13	0.91
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	387.05	532.42	365.94	195.06	153.85	145.99	170.97	399.22
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	1.69	1.87	1.27	1.41	2.01	4.46	4.29	3.3
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	215.39	194.69	288.25	258.08	181.31	81.87	85.09	110.7
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	246.32	411.12	137.83	-1.89	42.02	125.69	158.12	324.39
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	-312.39	-459.03	-305.81	-133.94	-84.36	-84.41	-98.72	-363.35
Inventories	- -	- -	- -	- -	- -	- -	11	16	19	19	16	22	31	23	80
Raw Materials	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	1	1	3	2
Work In Process	- -	- -	- -	- -	- -	- -	4	9	10	9	8	14	18	12	56
Finished Goods	- -	- -	- -	- -	- -	- -	6	5	9	9	7	7	12	8	22
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cash & Cash Equivalents	28	3	15	50	58	58	112	169	288	209	190	280	594	780	985
+ Preferred Equity and Hybrid Capital	- -	80	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	12	5	- -	- -	92	98	145	153	328	420	1,269	1,462	2,229	2,471	2,707
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Capital	-227	-14	137	298	318	218	301	504	922	902	1,271	1,114	1,411	1,373	2,502
Total Debt/Capital (%)	-5.15	-34.12	0.04	- -	28.9	45.09	48.1	30.38	35.56	46.59	99.89	131.14	158.03	179.98	108.21
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Sales	99	29	35	25	37	83	194	265	307	381	539	699	938	807	1,731
TTM EBITDA	33	-24	-43	-97	-164	-129	-47	-90	-209	-388	-310	-319	-203	-227	906
TTM Operating Income	31	-27	-45	-99	-167	-132	-64	-96	-193	-398	-375	-440	-349	-147	857
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	860
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	560

Multiples (USD)

Valuation Multiples API ChatGPT

No data availableFinancial data will appear here once available

Shares Outstanding	24	24	24	33	34	34	42	51	62	70	71	73	76	78	81
Diluted Weighted Avg Shares	24	24	13	32	34	34	39	47	59	66	70	72	75	77	88
Basic Weighted Avg Shares	14	14	13	32	34	34	39	47	59	66	70	72	75	77	80
Revenue per Share	6.97	2.03	2.7	0.8	1.09	2.43	4.96	5.68	5.22	5.77	7.64	9.74	12.53	10.5	21.76
EBITDA per Share	2.36	-1.7	-3.35	-3.08	-4.88	-3.78	-1.19	-1.92	-3.55	-5.88	-4.4	-4.44	-2.71	-2.95	11.39
Operating Income per Share	2.16	-1.89	-3.54	-3.15	-4.97	-3.88	-1.64	-2.07	-3.28	-6.03	-5.32	-6.13	-4.67	-1.91	10.77
Basic EPS, GAAP	- -	-11.2	-5.18	-2.97	-5.07	-4.17	-2.02	-2.75	-4.27	-6.64	-7.43	-7.79	-8.37	-4.73	8.58
Basic EPS from Cont Ops	2.18	-1.85	-4.02	-2.97	-5.07	-4.17	-2.02	-2.75	-4.27	-6.64	-7.43	-7.79	-8.37	-4.73	8.58
Diluted EPS, GAAP	- -	-6.71	-5.18	-2.97	-5.07	-4.17	-2.02	-2.75	-4.27	-6.64	-7.43	-7.79	-8.37	-4.73	7.73
Diluted EPS from Cont Ops	1.31	-1.11	-4.02	-2.97	-5.07	-4.17	-2.02	-2.75	-4.27	-6.64	-7.43	-7.79	-8.37	-4.73	7.73
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.46	-3.38	-3.66	-1.81	-3.7	-3.04	-0.26	-0.59	-1.68	-2.94	-3.57	-4.97	-2.12	-1.4	8.94
Free Cash Flow per Basic Share	-1.48	-3.39	-3.72	-1.96	-3.78	-3.09	-2.31	-0.93	-2.45	-3.79	-4.78	-7.1	-3.73	-2.37	5.17
Cash & Equivalents per Share	1.2	0.12	5.99	9.58	9.99	6.78	4.6	4.5	11.09	15.83	10.92	5.62	11.58	14.67	23.88
Book Value per Share	-10.08	-4.21	5.74	9.07	6.66	3.5	3.76	6.93	9.6	6.91	0.02	-4.75	-10.81	-14.13	-2.52
Tangible Book Value per Share	-10.08	-4.21	5.74	9.07	6.66	3.5	0.56	-8.55	-3.21	-4.53	-11.38	-15.53	-16.91	-16.72	-8.3

PTC Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)